clonoSEQ Assay Now Covered by Medicare for Multiple Myeloma and Acute Lymphoblastic Leukemia
The clonoSEQ Assay — a test that detects cancer…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
FDA Asked to OK Darzalex as Combo Therapy for Newly Diagnosed Group of Multiple Myeloma Patients
Janssen Biotech has asked that the U.S. Food…
Recruitment Begins in Phase 1 Trial of C-CAR088 for Multiple Myeloma
A Phase 1 trial in China is…
CLR 131 Significantly Extends Survival of Heavily Treated Multiple Myeloma Patients in Phase 1 Trial
Heavily treated multiple myeloma patients included in the first…
Ayala Partnering with Novartis on Investigational AL102 for Treatment of Multiple Myeloma
In a new agreement, Ayala Pharmaceuticals will work…
Revlimid Maintenance Extends Survival Without Disease Worsening in Myeloma Patients, Phase 3 Trial Shows
Long-term maintenance treatment with Revlimid (lenalidomide) significantly improves…
